Celvestrant 250 mg Injection
134.86$
105.19$
Celvestrant 250 mg injection is a targeted anticancer treatment specifically designed for postmenopausal women battling hormone receptor-positive, HER2-negative breast cancer. This innovative medication is particularly effective when used in combination with palbociclib for those with locally advanced or metastatic disease who have previously undergone endocrine therapy. Celvestrant functions by inhibiting estrogen's effects, thereby slowing the proliferation of cancer cells and helping to manage disease progression. It's crucial for patients to be aware of potential side effects, which may include hot flashes, fatigue, or gastrointestinal disturbances, and to discuss these with their healthcare provider. Regular monitoring is essential to ensure the treatment's effectiveness and adjust dosages as necessary. As with any cancer therapy, Celvestrant should only be administered under the guidance of a qualified healthcare professional. With its unique mechanism of action, Celvestrant represents a vital option in the ongoing fight against breast cancer, offering hope and improved outcomes for women in need.
الكمية
Active Pharmaceutical Ingredient
Uses
• Celvestrant 250 mg injection is primarily indicated for the treatment of hormone receptor-positive breast cancer. It works by targeting estrogen receptors, which can help inhibit the growth of cancer cells driven by estrogen. This makes it a valuable option for patients who have already undergone other treatments. The injection is often used when the cancer has progressed despite prior therapies.
• In addition to its role in advanced breast cancer, Celvestrant 250 mg injection can be used in cases where the cancer has metastasized. By reducing the activity of estrogen, it can help slow down the spread of cancer to other parts of the body. This is particularly important for improving the quality of life in patients with metastatic disease. The medication is typically administered in a clinical setting, ensuring proper monitoring.
• Celvestrant 250 mg injection is also useful in cases of breast cancer that are resistant to other hormonal therapies. When patients experience disease progression while on treatments like aromatase inhibitors, Celvestrant 250 mg injection may be considered. Its unique mechanism allows it to effectively target and inhibit cancer cell proliferation. This provides an alternative approach for managing difficult-to-treat cancer types.
• For patients with a specific subtype of breast cancer, Celvestrant 250 mg injection can be part of a comprehensive treatment plan. It may be combined with other therapeutic agents to enhance efficacy and target cancer more effectively. The injection is typically administered under the supervision of healthcare professionals who specialize in oncology. This ensures that patients receive personalized care tailored to their specific condition.
Benefits
Celvestrant Injection effectively reduces the symptoms associated with breast cancer, such as breast lumps, bloody nipple discharge, or changes in the shape or texture of the breast. Its mechanism of action involves altering the production of hormones that are essential for the growth and metastasis of breast cancer cells. It may also interact with other hormones or directly inhibit cancer growth. It is essential to receive Celvestrant 250 Injection by injection from a doctor or nurse as self-administration is not recommended.It is important to look at your doctor's instructions carefully.
Side Effects
As with all medicines, Celvestrant 250 mg Injection may cause some side effects. If you experience any of these side effects, you should contact your doctor or health care professional as soon as possible. Your doctor may be able to suggest ways in which these side effects can be managed or the severity of them reduced.
Most Common Side Effects
• Back pain
• Diarrhoea
• Vaginal bleeding
• Muscle and Joint pain
• Reaction in the injection site
• Vomiting
• Nausea
• Numbness
• Appetite loss
• Sweating
• Infection in the urinary tract
Common Side Effects
• Blood clots
• Low platelets count
• Liver failure
• Swelling in tongue, mouth, throat, and face
How To Use
The Celvestrant 250 mg Injection is administered by a healthcare professional or nurse in a hospital or clinic setting by intravenous infusion under the skin. The specific dosage and administration of Celvestrant 250 mg Injection will be determined by the patient's clinical condition, age, medical history, and other factors. It is important to note that this Celvestrant 250 mg should not be self-administered, and it is important to follow the instructions of the healthcare professional administering the Celvestrant 250 mg Injection.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Celvestrant Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Celvestrant 250 mg should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Celvestrant 250 mg Injection and report any unusual symptoms or changes in kidney function to their doctor. The dose of Celvestrant 250 mg may need to be adjusted in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Celvestrant 250 Injection. Celvestrant Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Celvestrant 250 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Celvestrant 250 Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Celvestrant 250 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Celvestrant 250 Injection may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Celvestrant 250 mg Injection may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Celvestrant 250 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Celvestrant 250 mg Injection is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Celvestrant 250 Injection such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.